Cargando…

Faecalibacterium: a bacterial genus with promising human health applications

In humans, many diseases are associated with alterations in gut microbiota, namely increases or decreases in the abundance of specific bacterial groups. One example is the genus Faecalibacterium. Numerous studies have underscored that low levels of Faecalibacterium are correlated with inflammatory c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín, Rebeca, Rios-Covian, David, Huillet, Eugénie, Auger, Sandrine, Khazaal, Sarah, Bermúdez-Humarán, Luis G, Sokol, Harry, Chatel, Jean-Marc, Langella, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410495/ https://www.ncbi.nlm.nih.gov/pubmed/37451743 http://dx.doi.org/10.1093/femsre/fuad039

Ejemplares similares

New Insights into the Diversity of the Genus Faecalibacterium
por: Benevides, Leandro, et al.
Publicado: (2017)

Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii
por: Martín, Rebeca, et al.
Publicado: (2018)

Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3
por: Lenoir, Marion, et al.
Publicado: (2020)

Gene co-expression network analysis of the human gut commensal bacterium Faecalibacterium prausnitzii in R-Shiny
por: Auger, Sandrine, et al.
Publicado: (2022)

Identification of Metabolic Signatures Linked to Anti-Inflammatory Effects of Faecalibacterium prausnitzii
por: Miquel, Sylvie, et al.
Publicado: (2015)

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic
por: Martín, Rebeca, et al.
Publicado: (2017)

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model
por: Martín, Rebeca, et al.
Publicado: (2015)

Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii
por: Auger, Sandrine, et al.
Publicado: (2022)

Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease
por: Lapiere, Alexia, et al.
Publicado: (2020)

Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models
por: Miquel, S., et al.
Publicado: (2016)

Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
por: Maioli, Tatiani Uceli, et al.
Publicado: (2021)

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
por: Bermúdez-Humarán, Luis G, et al.
Publicado: (2011)

Utilisation des bactéries lactiques comme vecteurs vaccinaux
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009)

Development of Mucosal Vaccines Based on Lactic Acid Bacteria
por: Bermúdez-Humarán, Luis G., et al.
Publicado: (2009)

A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain
por: Barone, Monica, et al.
Publicado: (2018)

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer
por: Jacouton, Elsa, et al.
Publicado: (2017)

Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes
por: Cornuault, Jeffrey K., et al.
Publicado: (2018)

Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe–Microbe Interactions
por: Martín, Rebeca, et al.
Publicado: (2016)

From Short- to Long-Term Effects of C-Section Delivery on Microbiome Establishment and Host Health
por: Ríos-Covian, David, et al.
Publicado: (2021)

New gene markers for classification and quantification of Faecalibacterium spp. in the human gut
por: Tanno, Hiroki, et al.
Publicado: (2023)

Description of a Newly Isolated Blautia faecis Strain and Its Benefit in Mouse Models of Post-Influenza Secondary Enteric and Pulmonary Infections
por: Verstraeten, Sophie, et al.
Publicado: (2022)

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
por: Martín, Rebeca, et al.
Publicado: (2013)

Preterm Delivery: Microbial Dysbiosis, Gut Inflammation and Hyperpermeability
por: Arboleya, Silvia, et al.
Publicado: (2022)

Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model
por: Aubry, Camille, et al.
Publicado: (2015)

Erratum to: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model
por: Aubry, Camille, et al.
Publicado: (2016)

Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses
por: Rossi, Oriana, et al.
Publicado: (2016)

Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway
por: Breyner, Natalia M., et al.
Publicado: (2017)

Impact of Oral Administration of Lactiplantibacillus plantarum Strain CNCM I−4459 on Obesity Induced by High-Fat Diet in Mice
por: Jacouton, Elsa, et al.
Publicado: (2023)

Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria
por: LeBlanc, Jean Guy, et al.
Publicado: (2017)

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice
por: Martín, Rebeca, et al.
Publicado: (2016)

Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models
por: de Moreno de LeBlanc, Alejandra, et al.
Publicado: (2015)

Strategies for the Identification and Assessment of Bacterial Strains with Specific Probiotic Traits
por: Torres-Maravilla, Edgar, et al.
Publicado: (2022)

Oral delivery of pancreatitis‐associated protein by Lactococcus lactis displays protective effects in dinitro‐benzenesulfonic‐acid‐induced colitis model and is able to modulate the composition of the microbiota
por: Breyner, Natalia M., et al.
Publicado: (2019)

Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium
por: Cortes-Perez, Naima G, et al.
Publicado: (2009)

Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis
por: Carvalho, Rodrigo D. De Oliveira, et al.
Publicado: (2017)

Genome Sequence and Assessment of Safety and Potential Probiotic Traits of Lactobacillus johnsonii CNCM I-4884
por: Boucard, Anne-Sophie, et al.
Publicado: (2022)

Lactococcus lactis engineered to deliver hCAP18 cDNA alleviates DNBS-induced colitis in C57BL/6 mice by promoting IL17A and IL10 cytokine expression
por: Noguès, Esther Borras, et al.
Publicado: (2022)

Faecalibacterium diversity in dairy cow milk
por: Savin, Keith W., et al.
Publicado: (2019)

Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice
por: Rochat, Tatiana, et al.
Publicado: (2007)

Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties
por: Jacouton, Elsa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_700rn6p9ms6hpq4f8gh2kknh2h